E. Wylie

Diabetic nephropathy.

S. Satchell, E. Wylie, 2012, Clinical medicine.

HtrA1: a novel regulator of physiological and pathological matrix mineralization?

E. Wylie, F. Wilkinson, A. Canfield, 2007, Biochemical Society transactions.

Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro.

Robert H. Jenkins, R. Foster, S. Satchell, 2013, The American journal of pathology.

Reactive Oxygen Species Modulate the Barrier Function of the Human Glomerular Endothelial Glycocalyx

R. Foster, S. Satchell, P. Mathieson, 2013, PloS one.

Title Reactive Oxygen Species Modulate the Barrier Function of theHuman Glomerular Endothelial Glycocalyx

R. Foster, S. Satchell, P. Mathieson, 2013 .

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.

G. Damodaran, S. Harper, D. Bates, 2015, Journal of the American Society of Nephrology : JASN.

Small Vessel Disease in CKD, Diabetes, Obesity and Hypertension

A. Heagerty, E. Wylie, R. Aghamohammadzadeh, 2015 .